Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Incidence of peripheral neuropathy in patients treated with etanidazole and cisplatin for esophageal cancer

Incidence of peripheral neuropathy in patients treated with etanidazole and cisplatin for esophageal cancer. Presented at the International Chemical Modifiers Meeting, Kyoto Japan. 1993.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.